SECONDARY MYELODYSPLASTIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION - REPORT OF 2 CASES

被引：0
|
作者：
CHAN, T [1 ]
JUNEJA, S [1 ]
WOLF, M [1 ]
JANUSZEWICZ, E [1 ]
COOPER, I [1 ]
机构：
[1] PETER MACCALLUM CANC INST,DEPT HAEMATOL & MED ONCOL,MELBOURNE,VIC 3000,AUSTRALIA
来源：
BONE MARROW TRANSPLANTATION | 1994年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
We report two cases of secondary myelodysplastic syndrome (SMDS) which followed successful treatment of a primary malignancy with high-dose chemotherapy supported by reinfusion of autologous stem cells. The SMDS was diagnosed 24 months and 40 months, respectively, following autografting. Both patients lived for 7 months after the diagnosis of SMDS. Our cases support the view that there is an increased risk of SMDS/acute leukemia following autologous marrow transplantation.
引用
收藏
页码：145 / 148
页数：4
相关论文
共 50 条
  • [21] MYELODYSPLASTIC SYNDROME ASSOCIATED WITH BONE-MARROW FIBROSIS
    LAMBERTENGHIDELILIERS, G
    ANNALORO, C
    ORIANI, A
    SOLIGO, D
    LEUKEMIA & LYMPHOMA, 1992, 8 (1-2) : 51 - 55
  • [22] BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME
    KAI, S
    SHINOHARA, Y
    ACTA HAEMATOLOGICA JAPONICA, 1989, 52 (08): : 1402 - 1411
  • [23] MR APPEARANCES OF BONE-MARROW IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION
    BOOTHROYD, AE
    SEBAG, G
    BRUNELLE, F
    PEDIATRIC RADIOLOGY, 1991, 21 (04) : 291 - 292
  • [24] SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A CASE WITH MYELODYSPLASTIC SYNDROME WHICH DEVELOPED FOLLOWING FANCONI-ANEMIA
    IKUSHIMA, S
    HIBI, S
    TODO, S
    SAWADA, T
    MATSUMOTO, Y
    IWAMI, H
    TSUNAMOTO, K
    KASUBUCHI, Y
    YABE, M
    KATO, S
    IMASHUKU, S
    BONE MARROW TRANSPLANTATION, 1995, 16 (04) : 621 - 624
  • [25] MYELODYSPLASTIC SYNDROME FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN ADDITIONAL LATE COMPLICATION OF CURATIVE CANCER-THERAPY
    MILLER, JS
    ARTHUR, DC
    LITZ, CE
    NEGLIA, JP
    MILLER, WJ
    WEISDORF, DJ
    BLOOD, 1993, 82 (10) : A455 - A455
  • [26] BONE-MARROW TRANSPLANTATION FOR WISKOTT-ALDRICH SYNDROME - REPORT OF 2 CASES WITH USE OF 2-MERCAPTOETHANE SULFONATE
    GOLDSOBEL, AB
    EHRLICH, RM
    MENDOZA, GR
    STIEHM, ER
    TRANSPLANTATION, 1985, 39 (05) : 568 - 570
  • [27] DONOR BUFFY COAT INFUSIONS FOR A PATIENT WITH MYELODYSPLASTIC SYNDROME WHO RELAPSED FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    TSUZUKI, M
    MARUYAMA, F
    KOJIMA, H
    EZAKI, K
    HIRANO, M
    BONE MARROW TRANSPLANTATION, 1995, 16 (03) : 487 - 489
  • [28] TREATMENT OF CHEDIAK-HIGASHI-SYNDROME BY ALLOGENIC BONE-MARROW TRANSPLANTATION - REPORT OF 10 CASES
    HADDAD, E
    LEDEIST, F
    BLANCHE, S
    BENKERROU, M
    ROHRLICH, P
    VILMER, E
    GRISCELLI, C
    FISCHER, A
    BLOOD, 1995, 85 (11) : 3328 - 3333
  • [29] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    ARNOLD, R
    HEIMPEL, H
    BONE MARROW TRANSPLANTATION, 1989, 4 : 101 - 103
  • [30] INTENSIVE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES
    LOFFLER, H
    SCHMITZ, N
    GASSMANN, W
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (03) : 619 - 631
12345